CompletedNCT03063827

Effect of Botulinum Toxin A on Neurogenic Detrusor Overactivity in Chronic Spinal Cord Injured Patients

Studying Hinman syndrome

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Buddhist Tzu Chi General Hospital
Principal Investigator: Hann-Chorng Kuo, M.D.
Department of Urology, Buddhist Tzu Chi General Hospital
Intervention: OnabotulinumtoxinA 200 UNT(drug)
Enrollment: 36 target
Eligibility: 18 years · All sexes
Timeline: 2010 – 2012

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03063827 on ClinicalTrials.gov

Other trials for Hinman syndrome

Additional recruiting or active studies for the same condition.

RECRUITINGNANCT04604951
Below the Belt: Non-invasive Neuromodulation to Treat Bladder, Bowel, and Sexual Dysfunction Following Spinal Cord Injury
University of British Columbia
ACTIVE NOT RECRUITINGNCT04924569
Continence Care Registry
Hollister Incorporated

See all trials for Hinman syndrome →

← Back to all trials